Chuxin Jiahe Shanghai Consultant Co., Ltd – Trademark Portfolio
Entity Type: 99
Chuxin Jiahe Shanghai Consultant Co., Ltd owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as COVASTRA, NURTURECARE, ROSY&GRAMMA, and ROSY & GRANDMA. Of these, 4 are registered. The portfolio spans 4 Nice Classification classes, led by Class 10 (Medical Apparatus) and Class 22 (Cordage). Headquartered in Shanghai.
Youqing Road, Minhang District
Room 801, No. 18, Lane 50
Shanghai 201199 , CN
Showing of trademarks Trademarks
Trademark Classifications
Chuxin Jiahe Shanghai Consultant Co., Ltd's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Chuxin Jiahe Shanghai Consultant Co., Ltd have?
Chuxin Jiahe Shanghai Consultant Co., Ltd has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does Chuxin Jiahe Shanghai Consultant Co., Ltd file in?
Chuxin Jiahe Shanghai Consultant Co., Ltd files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 22 (Cordage), Class 5 (Pharmaceuticals), Class 12 (Vehicles). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Chuxin Jiahe Shanghai Consultant Co., Ltd's most well-known trademarks?
Chuxin Jiahe Shanghai Consultant Co., Ltd's registered trademark portfolio includes well-known marks such as COVASTRA, NURTURECARE, ROSY&GRAMMA, and ROSY & GRANDMA. These are among 4 currently registered trademarks in the portfolio.
What is Chuxin Jiahe Shanghai Consultant Co., Ltd's trademark registration success rate?
Chuxin Jiahe Shanghai Consultant Co., Ltd has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.